<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Activated protein C resistance due to factor V Leiden (FVL) is a common genetic risk factor for <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> in humans </plain></SENT>
<SENT sid="1" pm="."><plain>Although the impact of FVL on the development of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> is well established, its effect on <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> is controversial </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: To determine the effect of the FVL mutation on <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> in the mouse, <z:mp ids='MP_0002169'>wild-type</z:mp> (Fv+/+), heterozygous FVL (FvQ/+), and homozygous FVL (FvQ/Q) mice underwent photochemical carotid arterial injury to induce occlusive <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>FvQ/Q mice formed occlusive thromboses 27+/-3 minutes (n=7) after the <z:hpo ids='HP_0003674'>onset</z:hpo> of injury, which was significantly shorter than that observed for Fv+/+ mice (56+/-7 minutes, n=9, P&lt;0.01), whereas FvQ/+ mice (41+/-7 minutes, n=5) were intermediate (P=0.5, compared with Fv+/+) </plain></SENT>
<SENT sid="4" pm="."><plain>To determine the source of FVL relevant to the enhanced vascular <z:mp ids='MP_0005048'>thrombosis</z:mp>, bone marrow transplantation experiments were performed between Fv+/+ and FvQ/Q mice </plain></SENT>
<SENT sid="5" pm="."><plain>FvQ/Q mice transplanted with Fv+/+ bone marrow formed occlusive thromboses at 35+/-5 minutes (n=7, P&lt;0.05 compared with Fv+/+ mice), whereas Fv+/+ mice transplanted with FvQ/Q bone marrow occluded at 59+/-7 minutes (n=6, P&lt;0.001 compared with FvQ/Q mice) </plain></SENT>
<SENT sid="6" pm="."><plain>To assess the effect of the FVL mutation on the development of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, FvQ/Q mice were crossed with the <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>-prone <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (ApoE)-deficient strain (ApoE-/-) to generate FvQ/Q,ApoE-/- mice </plain></SENT>
<SENT sid="7" pm="."><plain>By 52 weeks of age, FvQ/Q,ApoE-/- mice (n=8) had developed more aortic <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> (40+/-6% lesion area) compared with Fv+/+,ApoE-/- mice (15+/-3% lesion area; n=12, P&lt;0.02) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In conclusion, homozygosity for the FVL mutation in mice leads to enhanced <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The source of the FVL leading to accelerated <z:mp ids='MP_0005048'>thrombosis</z:mp> appears to be circulating, non-platelet-derived plasma FVL </plain></SENT>
</text></document>